Last updated on September 2017

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids


Brief description of study

The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Detailed Study Description

The study is a prospective, randomized, parallel group, double-blind, placebo-controlled phase 3 study investigating the efficacy and safety of OBE2109 alone and in combination with add-back therapy for the treatment of uterine fibroids. Subjects will be randomized to one of 5 treatment groups in a 1:1:1:1:1 ratio.

Clinical Study Identifier: NCT03070951

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Chief Medical Officer

Site reference ID 905
Chino, CA United States
  Connect »

Chief Medical Officer

Site reference ID 918
Huntington Park, CA United States
  Connect »

Chief Medical Officer

Site reference ID 902
San Diego, CA United States
  Connect »

Chief Medical Officer

Site reference ID 903
Denver, CO United States
  Connect »

Chief Medical Officer

Site reference ID 913
Bradenton, FL United States
  Connect »

Chief Medical Officer

Site reference ID 912
Orlando, FL United States
  Connect »

Chief Medical Officer

Site reference ID 924
Nampa, ID United States
  Connect »

Chief Medical Officer

Site reference ID 926
Covington, LA United States
  Connect »

Chief Medical Officer

Site reference ID 900
Metairie, LA United States
  Connect »

Chief Medical Officer

Site reference ID 901
Canton, MI United States
  Connect »

Chief Medical Officer

Site reference ID 916
Jefferson City, MO United States
  Connect »

Chief Medical Officer

Site reference ID 930
Albuquerque, NM United States
  Connect »

Chief Medical Officer

Site reference ID 914
Westerville, OH United States
  Connect »

Chief Medical Officer

Site reference ID 919
West Columbia, SC United States
  Connect »

Chief Medical Officer

Site reference ID 907
Houston, TX United States
  Connect »

Chief Medical Officer

Site reference ID 917
Madison, WI United States
  Connect »

Chief Medical Officer

Site reference ID 255
Pleven, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 258
Plovdiv, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 251
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 252
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 253
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 254
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 256
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 257
Sofia, Bulgaria
  Connect »

Chief Medical Officer

Site reference ID 281
Praha, Czechia
  Connect »

Chief Medical Officer

Site reference ID 286
Praha, Czechia
  Connect »

Chief Medical Officer

Site reference ID 287
Praha, Czechia
  Connect »